|
⚲
|
| Othera Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001203928 |
| Sale | 2008-10-10 ($10.8 M Offered, $10.6 M Sold) |
| Fund | |
| Phone | 4848792800 |
| Address | 730 Springdale Drive Exton, 19341 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Hans Mueller | |
| Rami Elghandour | |
| Thomas Morse | |
| Brian Murphy | |
| Katherine Crothall | |
| David Joseph |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
6MF 190, a series of SAX Capital Series Fund III, LP
✚
|
0.0 | |
|
6S ORLY Waterford TWP MI LLC
✚
|
0.0 | |
|
SHP Topco, Inc.
✚
|
0.0 | |
|
Shree Dhoot Trading & Agencies Ltd
✚
|
0.0 | |
|
SHS Altamonte Springs Ltd
✚
|
0.0 | |
|
Shum Albert
✚
|
0.0 | |
|
Shrinsk Jason L
✚
|
0.0 | |
|
Side Harm Feature, LLC
✚
|
0.0 | |
|
Sieradzki Richard D
✚
|
0.0 | |
|
6529 NFT Fund AI, LP - A1
✚
|
0.0 |